Skip to content
healthcare.dev

Simulect

NDC 0078-0331, basiliximab, injection, powder, for solution, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0331
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA103764
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0331 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BASILIXIMAB20 mg/5mL

Pharmacologic classes

Interleukin 2 Receptor Antagonists [MoA]; Interleukin 2 Receptor-directed Antibody Interactions [MoA]; Interleukin-2 Receptor Blocking Antibody [EPC]

Package NDCNDC-11Package
0078-0331-84000780331841 VIAL, SINGLE-USE in 1 CARTON (0078-0331-84) / 5 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1af01887-b69d-444b-91ed-ebfe12784440
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0078-0331

Use it

Look up 0078-0331 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0331 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0331. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.